CAR-T Immunotherapy

CAR-T Cell Immunotherapy

CAR-T therapy (chimeric antigen receptor T cell immunotherapy) is a revolutionary technology in the field of cancer immunotherapy. It breaks the limitation of "good and bad" in traditional treatment, and focuses on precise targeting, high efficiency and durability, and personalized customization. Provide new survival possibilities for patients with relapsed/refractory tumors.

Core Definition +

Through genetic engineering technology, the patient's own T cells are equipped with a "navigation system" (chimeric antigen receptor CAR), so that they can accurately identify and kill tumor cells, and at the same time form long-term memory immunity to reduce the risk of recurrence from the root. Personalized treatment plan customized by the patient's own cells.

Core Advantages +

Scope of application +

It is mainly used in relapsed/refractory hematological tumors (such as leukemia, lymphoma, multiple myeloma, etc.), and at the same time conducts clinical research in the field of melanoma, gastric cancer, glioma and other solid tumors, with significant therapeutic potential.

With the mission of science and technology innovation to help the world, relying on a professional team and a standardized system, we provide patients with one-stop personalized CAR-T treatment services, and protect the hope of life with cutting-edge technology.

🔬

🧬

80%+

Remission in ALL

Core Process

📋

Patient Evaluation

Patient evaluation: a professional team evaluates indications and formulates personalized plans and solutions;

🧬

Cell Collection and Transformation

Cell collection and transformation: Collect patient T cells, introduce CAR gene to complete the upgrade;

💉

In Vitro Expansion and Reinfusion

In vitro expansion and reinfusion: CAR-T cells were expanded and reinfused intravenously to start targeted killing;

📊

Postoperative Monitoring

Postoperative monitoring: closely monitor adverse reactions, regularly evaluate the curative effect and follow up for a long time.

Our Network

Partner Oncology Centers

🏥

Beijing Cancer Hospital

China's top-ranked oncology center with the nation's largest CAR-T treatment volume and multiple approved protocols.

Beijing Tier-3A CAR-T Approved

🏥

Ruijin Hospital Shanghai

Hematology excellence center with pioneering CAR-T clinical trials and international cooperation programs.

Shanghai Tier-3A Clinical Trials

🏥

Sun Yat-sen University Cancer Center

Southern China's premier cancer center with extensive CAR-T for solid tumor research and approved B-cell therapies.

Guangzhou Tier-3A Solid Tumors